Reproductive and fetal toxicity studies of histamine H3 receptor antagonist DL76 used in mice to prevent maximal electroshock-induced seizure

MLA

Salim M. Bastaki, et al. “Reproductive and Fetal Toxicity Studies of Histamine H3 Receptor Antagonist DL76 Used in Mice to Prevent Maximal Electroshock-Induced Seizure.” Frontiers in Pharmacology, vol. 15, June 2024. EBSCOhost, https://doi.org/10.3389/fphar.2024.1364353.

APA

Salim M. Bastaki, Yousef M. Abdulrazzaq, Marwan Abdelrahim Zidan, Mohamed Shafiullah, Saif Ghdayer Alaryani, Fatima Awad Alnuaimi, Ernest Adeghate, Sahar Mohsin, Amal Akour, Agata Siwek, Dorota Łażewska, Katarzyna Kieć-Kononowicz, & Bassem Sadek. (2024). Reproductive and fetal toxicity studies of histamine H3 receptor antagonist DL76 used in mice to prevent maximal electroshock-induced seizure. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1364353

Chicago

Salim M. Bastaki, Yousef M. Abdulrazzaq, Marwan Abdelrahim Zidan, Mohamed Shafiullah, Saif Ghdayer Alaryani, Fatima Awad Alnuaimi, Ernest Adeghate, et al. 2024. “Reproductive and Fetal Toxicity Studies of Histamine H3 Receptor Antagonist DL76 Used in Mice to Prevent Maximal Electroshock-Induced Seizure.” Frontiers in Pharmacology 15 (June). doi:10.3389/fphar.2024.1364353.